Wang B - Search Results

1

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial.

Zhao Y, Lv F, Chen S, Wang Z, Zhang J, Zhang S, Cao J, Wang L, Cao E, Wang B, Hu X. Zhao Y, et al. Among authors: wang l, wang z, wang b. BMC Cancer. 2018 Oct 22;18(1):1019. doi: 10.1186/s12885-018-4936-y. BMC Cancer. 2018. PMID: 30348118 Free PMC article. Clinical Trial.

2

Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma.

Wang J, Li J, Hong X, Tang W, Hu X, Wang B, Guo Y. Wang J, et al. Among authors: wang b. Oral Oncol. 2008 May;44(5):464-70. doi: 10.1016/j.oraloncology.2007.06.004. Epub 2007 Sep 7. Oral Oncol. 2008. PMID: 17826303

3

Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer.

Wang B, Zhang W, Hong X, Guo Y, Li J. Wang B, et al. Cancer Chemother Pharmacol. 2009 Jan;63(2):213-8. doi: 10.1007/s00280-008-0728-4. Epub 2008 Mar 15. Cancer Chemother Pharmacol. 2009. PMID: 18343924 Clinical Trial.

4

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin.

Zhu X, Leaw J, Gu W, Qian Y, Du H, Wang B, Hong X, Yin J. Zhu X, et al. Among authors: wang b. J Cancer Res Clin Oncol. 2008 Sep;134(9):929-36. doi: 10.1007/s00432-008-0376-4. Epub 2008 Mar 15. J Cancer Res Clin Oncol. 2008. PMID: 18343948 Clinical Trial.

5

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.

Wang B, Li XQ, Ma X, Hong X, Lu H, Guo Y. Wang B, et al. Am J Hematol. 2008 Oct;83(10):795-9. doi: 10.1002/ajh.21256. Am J Hematol. 2008. PMID: 18756548 Free article.

6

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC. Zhang J, et al. Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143151

7

Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.

Zhang J, Qiu LX, Wang ZH, Leaw SJ, Wang BY, Wang JL, Cao ZG, Gao JL, Hu XC. Zhang J, et al. Breast Cancer Res Treat. 2010 Nov;124(2):419-24. doi: 10.1007/s10549-010-0846-7. Epub 2010 Mar 19. Breast Cancer Res Treat. 2010. PMID: 20300826

8

Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.

Qiu LX, Zhang J, Li WH, Zhang QL, Yu H, Wang BY, Wang LP, Wang JL, Wang HJ, Liu XJ, Luo ZG, Wu XH. Qiu LX, et al. Mol Biol Rep. 2011 Apr;38(4):2295-9. doi: 10.1007/s11033-010-0361-2. Epub 2010 Nov 5. Mol Biol Rep. 2011. PMID: 21052845

9

Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients.

Sun S, Wang LP, Zhang J, Yang XY, Zhang QL, Jia Z, Hu XC, Wang BY. Sun S, et al. Med Oncol. 2012 Jun;29(2):418-24. doi: 10.1007/s12032-011-9839-6. Epub 2011 Feb 6. Med Oncol. 2012. PMID: 21298496 Clinical Trial.

10

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.

Wang L, Zhang Q, Zhang J, Sun S, Guo H, Jia Z, Wang B, Shao Z, Wang Z, Hu X. Wang L, et al. Among authors: wang z, wang b. BMC Cancer. 2011 Jun 15;11:248. doi: 10.1186/1471-2407-11-248. BMC Cancer. 2011. PMID: 21676217 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,131 results

Search Page

Filters